Loading...

Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition

OBJECTIVE: Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ketoacidosis (euDKA) in hopes that it will enhance recognition of this potentially life-threatening complicatio...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Diabetes Care
Main Authors: Peters, Anne L., Buschur, Elizabeth O., Buse, John B., Cohan, Pejman, Diner, Jamie C., Hirsch, Irl B.
Format: Artigo
Sprog:Inglês
Udgivet: American Diabetes Association 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4542270/
https://ncbi.nlm.nih.gov/pubmed/26078479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc15-0843
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!